[
  {
    "ts": null,
    "headline": "Kenvue Stock Hits All-Time Low, Turns Higher After-Hours",
    "summary": "Shares of consumer healthcare firm Kevnue dropped to a record low during regular trading Monday, then made up some ground afterhours as President Trump warned that acetaminophen, the active ingredient in Kenvue's Tylenol, is a potential cause of autism.  Kenvue shares were down 7.5% Monday, putting them down about 23% since the company's IPO shortly before its subsequent spinoff from Johnson & Johnson in mid-2023.  Kenvue stock hit a record low and was the worst performer in the S&P 500 Monday.",
    "url": "https://finnhub.io/api/news?id=7ee8659d9e091c5a16f9e09a129b5e9e889b7f1935c315cd3a71e9adce9344a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758579504,
      "headline": "Kenvue Stock Hits All-Time Low, Turns Higher After-Hours",
      "id": 136850407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Shares of consumer healthcare firm Kevnue dropped to a record low during regular trading Monday, then made up some ground afterhours as President Trump warned that acetaminophen, the active ingredient in Kenvue's Tylenol, is a potential cause of autism.  Kenvue shares were down 7.5% Monday, putting them down about 23% since the company's IPO shortly before its subsequent spinoff from Johnson & Johnson in mid-2023.  Kenvue stock hit a record low and was the worst performer in the S&P 500 Monday.",
      "url": "https://finnhub.io/api/news?id=7ee8659d9e091c5a16f9e09a129b5e9e889b7f1935c315cd3a71e9adce9344a8"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Announced the European launch of Its Shockwave Javelin Peripheral IVL Catheter",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 15 Best Stocks to Invest in for Financial Stability. On September 15, 2025, Johnson & Johnson (NYSE:JNJ) announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, which is a groundbreaking platform to treat peripheral artery disease (PAD). The Forward IVL System, which features a single […]",
    "url": "https://finnhub.io/api/news?id=3b65cc6c6819867fb017fa8226c5d7d6bafc2b37dcac233446f431f21f6345df",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758575734,
      "headline": "Johnson & Johnson (JNJ) Announced the European launch of Its Shockwave Javelin Peripheral IVL Catheter",
      "id": 136850408,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 15 Best Stocks to Invest in for Financial Stability. On September 15, 2025, Johnson & Johnson (NYSE:JNJ) announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, which is a groundbreaking platform to treat peripheral artery disease (PAD). The Forward IVL System, which features a single […]",
      "url": "https://finnhub.io/api/news?id=3b65cc6c6819867fb017fa8226c5d7d6bafc2b37dcac233446f431f21f6345df"
    }
  },
  {
    "ts": null,
    "headline": "Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials",
    "summary": "Kenvue rebuked claims of a connection between autism and acetaminophen and said it is “deeply concerned with the health risk this poses for expecting mothers.”",
    "url": "https://finnhub.io/api/news?id=d846c66a2f73bd56ca958df7e20499a4c6761bc9cf0c988e0c21d0b110b7699a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758567535,
      "headline": "Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials",
      "id": 136850409,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Kenvue rebuked claims of a connection between autism and acetaminophen and said it is “deeply concerned with the health risk this poses for expecting mothers.”",
      "url": "https://finnhub.io/api/news?id=d846c66a2f73bd56ca958df7e20499a4c6761bc9cf0c988e0c21d0b110b7699a"
    }
  },
  {
    "ts": null,
    "headline": "What is Kenvue? The Tylenol maker facing RFK Jr. scrutiny over autism claims",
    "summary": "Kenvue just opened its global headquarters in New Jersey. Here's what to know about the company and its CEO.",
    "url": "https://finnhub.io/api/news?id=04fb0c808c5a2135e878b990fc3c9ba73f648c7423944da0c9b429a5fa13c228",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758564313,
      "headline": "What is Kenvue? The Tylenol maker facing RFK Jr. scrutiny over autism claims",
      "id": 136850410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Kenvue just opened its global headquarters in New Jersey. Here's what to know about the company and its CEO.",
      "url": "https://finnhub.io/api/news?id=04fb0c808c5a2135e878b990fc3c9ba73f648c7423944da0c9b429a5fa13c228"
    }
  },
  {
    "ts": null,
    "headline": "J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?",
    "summary": "J&J shares gain 17.7% in three months, adding $63B to its market cap. Technical and pipeline momentum fuel investor interest.",
    "url": "https://finnhub.io/api/news?id=301fa5dee2bfb68927c72f4c6d99eeb220ebda6e42792338336bc1c45477fe9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758546960,
      "headline": "J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?",
      "id": 136850411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J shares gain 17.7% in three months, adding $63B to its market cap. Technical and pipeline momentum fuel investor interest.",
      "url": "https://finnhub.io/api/news?id=301fa5dee2bfb68927c72f4c6d99eeb220ebda6e42792338336bc1c45477fe9b"
    }
  },
  {
    "ts": null,
    "headline": "Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus",
    "summary": "Zacks highlights winners like LendingTree, AutoZone, and Johnson & Johnson as its proven stock-picking strategies continue to shine.",
    "url": "https://finnhub.io/api/news?id=8fb6ebb5acc6ca788e86a8281a3eaa8025a59de51b52da42059751ee16913dd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758546540,
      "headline": "Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus",
      "id": 136850412,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Zacks highlights winners like LendingTree, AutoZone, and Johnson & Johnson as its proven stock-picking strategies continue to shine.",
      "url": "https://finnhub.io/api/news?id=8fb6ebb5acc6ca788e86a8281a3eaa8025a59de51b52da42059751ee16913dd5"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Kenvue: “I Don’t Want to Dump it Right Here”",
    "summary": "Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently gave takes on. When a caller mentioned the company’s litigation risk, Cramer commented: “I don’t think the litigation risk is nearly as bad as people think. This stock is at 4.5%. It’s got new leadership. I don’t want to dump it right here. I […]",
    "url": "https://finnhub.io/api/news?id=ccb3edae461661b504d588335a1c915f590c39c2b6ea5b3c3744d02b784e50cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758526994,
      "headline": "Jim Cramer on Kenvue: “I Don’t Want to Dump it Right Here”",
      "id": 136850413,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently gave takes on. When a caller mentioned the company’s litigation risk, Cramer commented: “I don’t think the litigation risk is nearly as bad as people think. This stock is at 4.5%. It’s got new leadership. I don’t want to dump it right here. I […]",
      "url": "https://finnhub.io/api/news?id=ccb3edae461661b504d588335a1c915f590c39c2b6ea5b3c3744d02b784e50cd"
    }
  }
]